8-K: Hyperscale Data Amends $100M Preferred Stock Deal, Extends Closing

Hyperscale Data, Inc. and Ault & Company, Inc. amended their July 2025 Securities Purchase Agreement, extending the closing date for the sale of up to $100 million in Series H convertible preferred stock.

Summary

• Hyperscale Data, Inc. (the Company) entered into an amendment (the Amendment) to its Securities Purchase Agreement (the July 2025 SPA) with Ault & Company, Inc. (the Purchaser) on November 7, 2025.
• The original July 2025 SPA, dated July 31, 2025, involved the sale of up to 100,000 shares of Series H convertible preferred stock for a total purchase price of up to $100,000,000.00.
• The Amendment primarily modifies Section 2.1 of the July 2025 SPA, which pertains to the Closing Date for the securities purchase.
• The new Closing Date will occur on the later of (i) December 31, 2027, and (ii) one year following the date the Company completes the necessary actions to enable the issuance of Common Stock upon conversion of all convertible instruments, including the Series H Preferred Stock.
• The Purchaser retains the option to extend this Closing Date for an additional ninety (90) days by providing notice to the Company.

Sentiment

Score: 4

Explanation: The amendment extends the closing date for a significant capital raise, introducing uncertainty and delaying the anticipated funding, though the underlying agreement remains in place. This is a net negative, but not a complete deal collapse.

Positives

• The underlying Securities Purchase Agreement for up to $100 million in Series H convertible preferred stock remains in effect, indicating continued investor commitment.
• The board of directors of Hyperscale Data, Inc. approved the terms of the Amendment.

Negatives

• The closing date for the significant capital raise has been substantially delayed, pushing it out to at least December 31, 2027, or potentially even later.
• The closing is contingent on the Company completing actions to enable the issuance of common stock for conversion, introducing uncertainty regarding the timing of the capital infusion.

Risks

• Uncertainty regarding the Company's ability to complete the requisite actions to enable the issuance of common stock for conversion, which could further delay or jeopardize the closing of the capital raise.
• Potential for additional delays beyond the newly established dates, including the Purchaser's option to extend for 90 days.
• The extended timeline for capital infusion may impact the Company's strategic plans, operational funding, and growth initiatives.

Future Outlook

The future outlook for the up to $100 million capital raise is now significantly extended and contingent. The closing is pushed to at least December 31, 2027, and potentially one year after the company resolves its ability to issue common stock for conversion, with a further 90-day extension option for the purchaser. This indicates a longer-term horizon for the anticipated funding.

Management Comments

• Henry Nisser, President and General Counsel of Hyperscale Data, Inc., signed the Amendment on behalf of the Company.
• Milton C. Ault, III, Chief Executive Officer of Ault & Company, Inc., signed the Amendment on behalf of the Purchaser.

Industry Context

In the capital-intensive data center industry, timely access to funding is crucial for expansion and maintaining competitive advantage. A significant delay in a $100 million capital raise, as seen here, could signal challenges in the company's ability to execute its growth strategy or meet market demands, potentially impacting its competitive standing against peers with more stable or readily available financing.

Comparison to Industry Standards

• Without specific financial or operational results from Hyperscale Data, Inc., a direct comparison to industry benchmarks for performance is not feasible based solely on this filing.
• However, significant delays in closing substantial capital raises are generally viewed unfavorably compared to industry norms, where companies typically aim for efficient and timely funding to support strategic initiatives.

Corporate Governance

Stakeholder Impact

• Shareholders: Face delayed capital infusion and increased uncertainty regarding the timing and completion of the $100 million financing, which could impact share price and future growth prospects.
• Investors (Ault & Company, Inc.): Have agreed to a significantly extended timeline for their investment, indicating a longer holding period before the full conversion and realization of their preferred stock.

Next Steps

• The Company must complete the requisite actions to enable it to issue shares of Common Stock to persons holding instruments convertible into Common Stock, including the Series H Preferred Stock, before the capital raise can fully close.

Key Dates

Recommendation

While the $100 million capital raise remains in place, the significant extension of the closing date introduces considerable uncertainty and delays the anticipated financial strengthening. Investors should hold to monitor the company's progress in enabling common stock conversion and the eventual closing of this financing, as the delay could signal underlying operational or regulatory hurdles that need to be resolved before the capital can be fully deployed.

Keywords

Hyperscale Data, Ault & Company, Securities Purchase Agreement, Series H Preferred Stock, Convertible Preferred Stock, Capital Raise, Closing Date Extension, SEC Filing, 8-K, Corporate Governance